/PRNewswire/ Sapiens Americas, a wholly owned subsidiary of Sapiens International Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider of.
CMS is increasing the payment for administering at-home Covid-19 vaccinations from around $40 to $75 per dose. The move comes amid the Biden administration's push to boost vaccinations nationwide, including among older adults who may not be able to access vaccine sites.
The FDA has approved Prevnar 20, a Pfizer vaccine that protects against 20 pneumococcal strains seven more than the company’s blockbuster Prevnar 13. But others are on the big pharma company’s heels with vaccine candidates that aim to match or even beat the Pfizer pneumococcal vaccines.
Updated:
Share Article
AAA
Non-life insurers have registered a 11.35% rise in gross direct premium underwritten for May, a growth boosted by the continued demand for health products.
Flash figures issued by insurance regulator IRDAI show the non-life segment comprising general, standalone health as well as two specialised PSU insurers’ gross direct premium underwritten at ₹12,316.50 crore. In May 2020, it was ₹11,061 crore.
Of this, general insurers, who also deal in health, posted a 7.2% rise to ₹10,8233 crore. Standalone private health insurers stood out posting a 66.6% rise to ₹1,407 crore.
The pattern, however, is not new with the rise in the number of people contracting COVID-19 pushing up the demand for health insurance products since last year. IRDAI had also mandated the insurers dealing in health products to introduce two standard covers for COVID-19.